CD39 Activators

The class of CD39 activators comprises a diverse set of compounds that modulate CD39 enzymatic activity, leading to increased hydrolysis of ATP and ADP and subsequent adenosine production. ARL 67156, ARL 67156 HCl, Suramin, and POM-1, while some act as inhibitors, indirectly activate CD39 by preventing the hydrolysis of ATP and ADP, resulting in elevated extracellular ATP levels. This accumulation serves as a substrate for CD39, leading to increased adenosine production. Sodium Nitroprusside and EGCG activate CD39 through distinct mechanisms. Sodium Nitroprusside releases nitric oxide (NO), which stimulates CD39 through a signaling cascade involving guanylate cyclase and cGMP. EGCG, with its antioxidant properties, enhances the reduction of disulfide bonds in CD39, promoting its enzymatic activity and increasing ATP and ADP hydrolysis.

Zinc Chloride and Sodium Orthovanadate act as cofactors and inhibitors, respectively, influencing CD39 activity. Zinc Chloride acts as a cofactor for CD39, promoting the hydrolysis of ATP and ADP. Sodium Orthovanadate inhibits tyrosine phosphatases, leading to increased phosphorylation and activation of CD39. Peganum Harmala Extract, containing harmine, inhibits NTPDase, increasing ATP and ADP availability for CD39. Apyrase, while not a chemical, enzymatically activates CD39 by hydrolyzing ATP and ADP. Sodium Pyrophosphate modulates extracellular inorganic phosphate levels, influencing CD39 enzymatic activity and promoting adenosine production. In summary, the CD39 activators class encompasses a variety of compounds with diverse mechanisms of action. These compounds serve as valuable tools for understanding the regulatory mechanisms governing CD39 activity and its role in modulating extracellular purine levels, specifically ATP and ADP hydrolysis leading to adenosine production within different cellular contexts.